Nom du produit:1-(6-(Azepan-1-yl)pyrimidin-4-yl)-1H-pyrazole-3-carboxylic acid
IUPAC Name:1-[6-(azepan-1-yl)pyrimidin-4-yl]-1H-pyrazole-3-carboxylic acid
- CAS：1713463-31-0
- Formule moléculaire：C14H17N5O2
- Pureté：97%
- Numéro de catalogue：CM292498
- Poids moléculaire：287.32
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:1713463-31-0
- Formule moléculaire:C14H17N5O2
- Point de fusion:-
- Code SMILES:O=C(C1=NN(C2=NC=NC(N3CCCCCC3)=C2)C=C1)O
- Densité:
- Numéro de catalogue:CM292498
- Poids moléculaire:287.32
- Point d'ébullition:
- N° Mdl:
- Stockage:
Category Infos
- Pyrazoles
- Pyrazoles are organic compounds of the general formula C3H3N2H. It is a five-membered heterocycle consisting of three carbon atoms and two adjacent nitrogen atoms. As an H-bond-donating heterocycle, pyrazole has been used as a more lipophilic and metabolically more stable bioisomer of phenol. Pyrazoles have attracted more and more attention due to their broad spectrum of action and strong efficacy.
- Pyrazone
- Custom pyrazone for customers from all over the world are our main business.
- Pyrimidines
- Pyrimidine, also known as 1,3-diazobenzene, is a heterocyclic compound with the chemical formula C4H4N2. Pyrimidine is formed by substituting 2 nitrogen atoms for 2 carbons in the meta-position of benzene. It is a diazine and retains its aromaticity. Derivatives of pyrimidine widely exist in organic macromolecular nucleic acids, and many drugs also contain pyrimidine rings. In nucleic acids, three nucleobases are pyrimidine derivatives: cytosine, thymine and uracil. There are a variety of pyrimidine-containing drugs on the market, most of which are kinase inhibitors.
- Azepanes
- The use of azepane as a scaffold for drug discovery remains of interest. The azepane linker is the key to efficient activity. A number of seven-membered ring derivatives have been prepared or investigated for their potential or actual pharmacological properties. Examples include azaalkane derivatives as PKB (protein kinase B) inhibitors.
Recherche 
+86 21 5895 0110 
